Related Experiment Videos
Mutation analysis of the BCL10 gene in childhood solid malignancies
Jiangyong Miao1, Takeshi Kusafuka, Yuko Udatsu
1Department of Pediatric Surgery, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Medical and Pediatric Oncology
|October 12, 2002
Summary
Genetic analysis of the BCL10 gene in pediatric solid cancers revealed no mutations. These findings suggest BCL10 mutations are unlikely to drive most childhood malignancies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The BCL10 gene, involved in apoptosis signaling, is located on chromosome 1p22.
- BCL10 mutations are implicated in various lymphomas, solid tumors, and hepatocellular carcinoma, suggesting a role in tumorigenesis.
- Chromosome 1 abnormalities are common in pediatric solid tumors, prompting investigation of BCL10 in this context.
Purpose of the Study:
- To investigate the role of BCL10 gene mutations in pediatric solid malignant tumors.
- To analyze genomic alterations within the BCL10 gene in a cohort of pediatric cancer samples.
Main Methods:
- Analysis of 95 pediatric solid cancer tissues.
- PCR-Single Strand Conformation Polymorphism (PCR-SSCP) method to examine three exons encoding the BCL10 coding region.
- Direct sequencing of samples with aberrant band patterns.
Main Results:
- Six nucleotide changes were detected in total: two intronic and four exonic.
- Three of the four exonic changes resulted in amino acid substitutions (Ala5Ser, Thr162Met, Gly213Glu).
- Identical nucleotide changes were found in non-tumor tissues, indicating they are genetic polymorphisms, not tumor-specific mutations.
Conclusions:
- This study is the first genetic analysis of the BCL10 gene in pediatric solid malignant tumors.
- The findings suggest that BCL10 mutations are unlikely to be a significant mechanism in the pathogenesis of most childhood malignancies.
- BCL10 genetic alterations do not appear to be a common driver in the studied pediatric solid tumors.